The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 132, No 10, 1409-1417.
© 2001 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AL-HASHIMI, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AL-HASHIMI, I.
Related Collections
Right arrow Periodontics

CLINICAL PRACTICE

JADA Continuing Education

The management of Sjögren’s syndrome in dental practice



IBTISAM AL-HASHIMI, B.D.S., M.S., Ph.D.

Background. Sjögren’s syndrome, or SS, is a multisystem inflammatory disorder of the exocrine glands with a wide range of extraglandular involvement. Symptoms of dry eyes and xerostomia, although not invariably present, are characteristic features of SS. An increased risk of oral and dental diseases is a prominent consequence of SS.

Types of Studies Reviewed. The author reviewed recent medical and dental studies that have advanced our understanding of the causes and treatment of SS. She particularly focused on studies addressing the diagnosis and treatment of the oral component of the disease.

Results. Sjögren’s syndrome is a widely underdiagnosed disease. A delay in the diagnosis of SS may have a significant physical, psychological and economic impact on the affected person. The pathogenesis of SS appears to involve a number of factors: immunological, genetic, hormonal and possibly infectious. Successful management of SS requires a multidisciplinary approach, and the dentist plays an essential role in the diagnosis and treatment of the disease.

Oral Implications. Impairment of salivary function in SS increases the risk of developing oral diseases. Effective management of oral health comprises enhancement of salivary output (cholinergic agonist drugs such as pilocarpine or cevimeline) and prevention and treatment of dental caries, oral candidiasis and allergic mucositis. Finally, periodic evaluation of various clinical and laboratory parameters is needed to monitor disease status.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. S. Kassan and H. M. Moutsopoulos
Clinical Manifestations and Early Diagnosis of Sjogren Syndrome
Arch Intern Med, June 28, 2004; 164(12): 1275 - 1284.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
T. Beikler and T. F. Flemmig
IMPLANTS IN THE MEDICALLY COMPROMISED PATIENT
Critical Reviews in Oral Biology & Medicine, July 1, 2003; 14(4): 305 - 316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2001 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.